ArticlePneumonia (Nathan Qld.)2017
Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspective.
Article in Pneumonia (Nathan Qld.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.
- Costs of management of acute respiratory infections in older adults: A systematic review and meta-analysis.Journal of global health · 2022Pooled it
- Factors Associated with 30-Day Non-Return to Pre-Hospital Residence in Older Patients Hospitalized with Pneumonia or Lower Respiratory Tract Infection: The Role of Serum Albumin and Early Treatment Failure.Geriatrics (Basel, Switzerland) · 2026Article
- Appropriateness of empiric antibiotic therapy for community-acquired pneumonia: A multicenter cross-sectional study.Exploratory research in clinical and social pharmacy · 2025Article
- Effects of Broad-Spectrum Antimicrobials on Patients with Community-Acquired Pneumonia with Low Risk for Drug-Resistant Pathogens: Historical Cohort Study in Japan.Infectious diseases and therapy · 2025Article
- Resource utilisation and cost of hospitalisation with community-acquired pneumonia among older adults in India, 2018-2020.BMJ public health · 2025Article
- Relationships between human serum albumin levels and septic shock, in-hospital, and out-of-hospital mortality in elderly patients with pneumonia in different BMI ranges.Pneumonia (Nathan Qld.) · 2024Article
- Healthcare costs for hospitalized COVID-19 patients in a Japanese university hospital: a cross-sectional study.Cost effectiveness and resource allocation : C/E · 2023Article
- The effect of lifestyle on the mortality associated with respiratory diseases in the general population.Scientific reports · 2023Article
- Increased Risk of Hospitalization for Pneumonia in Italian Adults from 2010 to 2019: Scientific Evidence for a Call to Action.Vaccines · 2023Article
- Cost of acute respiratory illness episode and its determinants among community-dwelling older adults: a four-site cohort study from India.BMJ public health · 2023Article
- Burden of illness associated with pneumococcal infections in Japan - a targeted literature review.Journal of market access & health policy · 2022Review
- Prevalence, Antimicrobial Resistance, and Associated Factors ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022Article
- Interrupted time-series analyses of routine vaccination program for elderly pneumonia patients in Japan; an ecological study using aggregated nationwide inpatient data.Human vaccines & immunotherapeutics · 2021Article
- Incidence, risk factors, and viral etiology of community-acquired acute lower respiratory tract infection among older adults in rural north India.Journal of global health · 2021Article
- Multiresistant Bacterial Pathogens Causing Bacterial Pneumonia and Analyses of Potential Risk Factors from Northeast Ethiopia.International journal of microbiology · 2021Article
- Real-world evaluation of costs of illness for pneumonia in adult patients in Dubai-A claims database study.PloS one · 2021Article
- The Performance of CURB-65 and PSI for Predicting In-Hospital Mortality of Community-Acquired Pneumonia in Patients with Type 2 Diabetes Compared with the Non-Diabetic Population.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021Article
- Risk for prolonged hospitalization and mortality in aged community acquired pneumonia patients: a retrospective study in Japan.Journal of clinical biochemistry and nutrition · 2020Article
- Household Costs Associated with Hospitalization of Children with Severe Pneumonia in Quito, Ecuador.The American journal of tropical medicine and hygiene · 2020Article
- Development of a claims-based algorithm to identify potentially undiagnosed chronic migraine patients.Cephalalgia : an international journal of headache · 2019Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to estimate the economic burden of community-acquired pneumonia (CAP) among elderly patients in Japan. In addition, the study evaluated the relationship between total treatment cost and CAP risk factors.
methodsAn administrative database was searched for elderly patients (≥ 65 years old) who had pneumonia (ICD-10 code: J12-J18) and an antibiotic prescription between 1 June 2014 and 31 May 2015. The all-cause total healthcare costs of outpatient and inpatient CAP episodes were calculated.
resultsThis study evaluated data from 29,619 patients with CAP who experienced 14,450 outpatient CAP episodes and/or 20,314 inpatient CAP episodes. The mean ages were 77.5 ± 8.0 years and 81.5 ± 8.2 years among the outpatient and inpatient groups, respectively. The median treatment costs were US$346 (interquartile range: $195-551) per outpatient episode and US$4851 (interquartile range: $3313-7669) per inpatient episode. More severe cases had increased treatment costs at the treating hospitals. Male sex, diabetes, chronic obstructive pulmonary disease, and liver dysfunction were associated with increased total treatment costs, while dementia, dialysis, and rheumatism were associated with high costs of treating a CAP episode.
conclusionsThe economic burden of CAP might be decreased by reducing the number of hospitalizations for mild CAP and the incidence of severe CAP. Therefore, preventative care (e.g. oral hygiene or pneumococcus vaccination) is recommended for patients with related risk factors, such as male sex, older age, diabetes, chronic obstructive pulmonary disease, liver dysfunction, rheumatism, dementia, or dialysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.